BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 23, 2017
View Archived Issues
ALX-1141 to enter clinical development for the treatment of osteoarthritis
Read More
Rasagiline does not add benefit to standard therapy in ALS trial
Read More
Proof-of-concept study finds potassium-channel opener ezogabine ameliorates depression
Read More
Complete disease correction using gene therapy in novel model of muccopolysaccharidosis type IIID
Read More
Phase I results for CPI-613 plus modified FOLFIRINOX in patients with metastatic pancreatic cancer
Read More
Cariprazine granted positive opinion in Europe for the treatment of schizophrenia
Read More
FDA grants rare pediatric disease designation for EF-022
Read More
AC Immune enters research collaboration with Essex Bio-Technology
Read More
EMA committee gives positive opinion to brodalumab for plaque psoriasis
Read More
eFFECTOR Therapeutics identifies novel MNK1/2 inhibitors
Read More
Emmyon patents new furostan-3-ol derivatives
Read More
NDUFS7 gene polymorphism tied to obsessive-compulsive disorder risk
Read More
University of Dundee and Corbin Therapeutics agree to identify USP15 inhibitors
Read More
Shire gives update on phase I/II study of SHP-656 for hemophilia A
Read More
Xynomic Pharma and UCSF to conduct phase II/III study of abexinostat in RCC
Read More
FDA approves Actemra as first therapy to treat giant cell arteritis
Read More
Nektar and Takeda to explore combinations of NKTR-214
Read More
Otsuka reports topline results from phase III study of tolvaptan in ADPKD
Read More
ViaCyte cleared to begin trial of PEC-Direct in U.S. and Canada
Read More
EMA committee recommends approval of Oxervate for neurotrophic keratitis
Read More
Celgene reports positive results from RADIANCE study of ozanimod
Read More
New mouse model of pulmonary hypertension induced by oxidized lipids presented
Read More
FDA approves Kevzara for rheumatoid arthritis
Read More
Zealand reports phase IIa results for dasiglucagon in type 1 diabetes
Read More